已发表的部分文献: 标题:Prevention of transcriptional silencing by a replicator-binding complex consisting of SWI/SNF, MeCP1, and hnRNP C1/C2.作者:Huang L, Fu H, Lin CM, Conner AL, Zhang Y, Aladjem MI;杂志名称:Mol Cell Biol 标题:Comprehensive epigenetic analysis using oral rinse samples: a pilot study.作者:Kusumoto T, Hamada T, Yamada N, Nagata S, Kanmura Y, Houjou I, Kamikawa Y, Yonezawa S, Sugihara K;杂志名称:J Oral Maxillofac Surg 标题:A replication-dependent passive mechanism modulates DNA demethylation in mouse primordial germ cells.作者:Ohno R, Nakayama M, Naruse C, Okashita N, Takano O, Tachibana M, Asano M, Saitou M, Seki Y;杂志名称:Development 标题:Micro-RNA-204 Participates in TMPRSS2/ERG Regulation and Androgen Receptor Reprogramming in Prostate Cancer.作者:Todorova K, Metodiev MV, Metodieva G, Mincheff M, Fernández N, Hayrabedyan S;杂志名称:Horm Cancer 标题:Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.作者:Serravalle S, Bertuccio SN, Astolfi A, Melchionda F, Pession A;杂志名称:Biomed Res Int 标题:Combination Chemoradiotherapy with Temozolomide, Vincristine, and Interferon-β Might Improve Outcomes Regardless of O6-Methyl-Guanine-DNA-Methyltransferase (MGMT) Promoter Methylation Status in Newly Glioblastoma作者:Asano K. et. al.;杂志名称:BMC Cancer 标题:Saliva Gene Promoter Hypermethylation as a Biomarker in Oral Cancer.作者:Rapado-González Ó, López-Cedrún JL, López-López R, RodrÃguez-Ces AM, Suárez-Cunqueiro MM;杂志名称:J Clin Med Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。